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IN order to investigate the effects of varying the
rate of flow on endothelial integrity the rat
isolated small intestinal vasculature was perfused
at 1, 5, 10 or 20ml/min with a gelatin-containing
physiological salt solution (GPSS), followed by an
injection of colloidal carbon suspension (CC).
Significantly greater microvascular CC leakage
occurred at 1 or 5ml/min than at 10 or 20ml/
mitt. CC leakage at the two slower rates of flow
was reduced by adding red blood cells to the
GPSS, suggesting that the microvascular endothe-
Hum became hypoxic when perfused with GPSS
at 1 or 5 ml/min. After perfusion at 20ml/min
with GPSS containing resiniferatoxin (1 gM) or 5-
hydroxytryptamine (100M), CC leakage was
sicantly lower than after similar perfusion at
10ml/min. Two nitric oxide (NO) synthesis
blockers, N-nitro-L-arginine methyl ester (L-NAME,
100M) and methylene blue (20M), and an NO
scavenger CPTIO (100M) each increased CC leak-
age. This suggests that NO was being produced at
perfusion rates of 10 or 20ml/min. Sodium nitro-
prusside (10M), 8-bromo-cGMP (100M) and
BN52021 (10gM) each significantly reduced CC
leakage in the presence of L-NAME.
Key word: BN52021, Colloidal carbon, Hypoxia, Micro-
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Introduction
Colloidal carbon (CC) has been used routinely
in this laboratory as a marker for assessing acute
inflammatory responses to various compounds, in
the microvasculature of rat small intestinal villi
during perfusion in vitro.1-5 However, small
amounts of CC leak even in control preparations.
Tissue hypoxia, due to the relatively low oxygen-
carrying capacity of the artificial perfusate being
used, was one possible explanation. We now
report the effect on CC leakage of varying the
rate of perfusion and of increasing the oxygen-
carwing capacity of the perfusate by addition of
pig washed red blood cells (RBCs). The possibi-
lity that the endothelium might be producing an
endogenous anti-inflammatory substance such as
nitric oxide, particularly at higher rates of perfu-
sion, has been investigated, along with possible
associated alterations in the release of platelet-
activating factor (PAF).
Materials and Methods
Perfusion of rat isolated mesentery and small
intestine: The method used has been described
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in detail previously. Rats were killed by inhala-
tion of chloroform vapour and the anterior
mesenteric artery cannulated. The mesentery with
the small intestine still attached was removed to a
bath of gelatin-containing physiological salt solu-
tion (GPSS) with RBCs added where appropriate
(GPSS + RBC) at 37C. Rat blood was flushed
from the vasculature using 50 ml of either GPSS
or GPSS + RBC delivered at a rate of 10 ml/min.
Re-circulation of the perfusate was then com-
menced at flow rates of 1, 5, 10 or 20 ml/min for
15 min, with perfusion pressures during the last
5 min being recorded. Then 0.5ml of CC sus-
pension was injected near to the cannula and the
perfusate thereafter allowed to run to waste. The
volume of perfusate used for flushing CC from
the vessel lumen was 80 ml in all cases. Flushing
began at the rate of flow under specific investiga-
tion, but the last 40ml of perfusate was always
delivered at 20 ml/min to ensure complete clear-
ance of CC from the lumen. This represents only
a slight departure from the protocol adopted in
previous work.1-5 Where GPSS was used as a
perfusate, 2 ml of rat washed RBCs were injected
into ,the cannula after flushing out CC to provide
a visual check on vascular patency during sub-
sequent microscopic examination. The prepara-
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tion was removed from the organ bath at this
point and placed in a bath of cold normal saline
for further dissection of the intestine.
Where appropriate, 5-hydroxytryptamine (5HT,
100btM) or resiniferatoxin (RFX, l l.tM), was
added to the perfusate for the last 5 min of the 15
min period of re-circulation. N-Nitro-L-arginine
methyl ester HCl (L-NAME, 201.tM, 100l.tM, or
500btM), N-nitro-D-arginine methyl ester HCl
(D-NAME, 100 l.tM), 2-(4-carboxyphenyl)-4,4,5,5-
tetramethylimidazoline-1-oxyl-3-oxide (CPTIO,
100 tM) or methylene blue (20 l.tM) were included
in the perfusate from the start of the 15 min
period of re-circulation. However, those com-
pounds being tested as possible antagonists to the
effects of L-NAME, i.e. 8-bromo-cGMP (8BrcGMP,
500btM), sodium nitroprusside (SNP, 10btM) or
BN52021 (10btM), were added to the perfusate
starting 2 min prior to adding the L-NAME.
Preparation of the intestine for image analysis:
Segments of small intestine were opened length-
ways and stapled to xylene-resistant plastic cover-
slips. After fixation, dehydration and clearance in
xylene, villi microvessels were photographed at
x 100 magnification. The resulting negative
micrographs were subjected to image analysis.
The area depicting CC deposits was expressed as
a percentage of the total area of each micro-
graph, as described earlier.-5
Statistical analysis: Bonferroni’s test was used for
comparing multiple groups with a single control
group.
Perfusates: GPSS had the following composition
(mM): NaC1, 138; KCl, 5; NaHCO3, 10.1; MgCl2,
1.06; NaHiPO4, 0.416; CaC12, 2; glucose, 10; plus
2% gelatin, giving pH 7.4. Pig washed RBCs (20%
v/v for flow rates of 1 or 5 ml/min, or 10% v/v
for flow rams of 10 or 20 ml/min) were added as
required (GPSS + RBC). Perfusates were gassed
throughout with 95% O2 and 5% CO2.
Chemicals used: 5HT, RFX, L-NAME, D-NAME and
8BrcGMP were all obtained from Sigma Chemical
Co., Poole, UK; methylene blue was obtained
from Hopkin & Williams, Chadwell Heath, UK;
SNP was obtained from David Bull Laboratories,
Warwick, UK; CPTIO was obtained from Tocris
Cookson, Bristol, UK; BN52021 was kindly given
by Dr P. Braquet, Henri Beaufors Research
Laboratories, Le Plessis Robinson, France. RFX
and BN52021 were initially dissolved in dimethyl-
sulphoxide. The latter solvent was biologically
inert at the final concentration used in the perfu-
sate. All other compounds were prepared as
aqueous solutions. The dose volume added to
the reservoir of perfusate was 0.2ml in each
case. All solutions containing SNP were protected
from light.
Gelatin was obtained from Thornton Ross,
Huddersfield, UK; Thermanox xylene-resistant
coverslips were obtained from Nunc Inc., Naper-
ville, IL, USA; colloidal carbon suspension
(Gunther Wagner, batch C11/1431a) was
obtained from Pelikan Inks, Hanover, Germany.
Results
Effects ofaltering the rate ofperfusion: When the
intestinal vasculature was perfused with GPSS at
either 1 or 5mL/min there was a significant
leakage of CC into the microvessel walls in the
villi (Fig. 1). At higher rates of flow (10 or 20 mL/
rain) the leakage of CC was significantly less
(Fig. 1). Perfusion pressures rose progressively
with increasing rates of flow (Table 1), but they
remained more or less constant over the 5 min
period of measurement at any given rate of per-
fusion (Table 1).
Significant further leakage of CC occurred
when either 5HT (100 I.tM) or RFX (1 I.tM) was
added to the GPSS perfusate at 10 mL/min during
the 5 min immediately prior to injection of CC
(Table 2), confirming earlier reports.
2-4 When
perfusion was conducted at 20 ml/min, however,
the leakage of CC in the presence of these two
compounds was not significantly different from
control values at that rate of flow (Table 2).
Perfusion pressures were increased significantly
in the presence of 5HT at both rates of flow, but
not in the presence of RFX (Table 1).
Effects of adding RBCs to the perfusate: The
above results suggested that tissue hypoxia, due
to a rather low oxygen-carrying capacity of GPSS,
particularly when used at perfusion rates of only
1 or 5mL/min, might be responsible for CC
leakage seen under these control conditions.
When RBCs were added to GPSS (Fig. 1) the
leakage of CC at flow rates of 1 or 5 ml/min was
reduced to the levels akin to those recorded in
the absence of RBCs at two higher rates of flow
(10 or 20ml/min). This confirmed that indeed
hypoxia was a factor in promoting CC leakage at
the two lower perfusion rates. At 10 or 20ml/
min, however, addition of RBCs to GPSS had no
significant effect on the leakage of CC, suggesting
that tissue hypoxia did not occur even in the
absence of RBCs. As expected, perfusion pres-
sures (PP 10 values) recorded in the presence of
RBCs wre higher than with GPSS alone and are
given in Table 1. This reflects the viscosity-
enhancing effect of the RBCs.
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FIG. 1. CC leakage assessed by image analysis and expressed as
% of frame area (see Materials and Methods). *p < 0.05 (Bon-
ferroni’s test) compared with GPSS alone at the same perfusion
rate. **p< 0.05 (Bonferroni’s test) compared with GPSS+L-
NAME at the same perfusion rate. Results are given as mean ___
S.E.M. n 5 to 12., GPSS + BN 10 IM) + L-NAME (100 IM);
l, GPSS + BN (IOIM);, GPSS + RBC + L-NAME (1001M); , GPSS + L-NAME (100 IM);A, GPSS + RBC; [, GPSS.
Possible involvement ofNO: Figure 1 shows that
L-NAME (100l.tM), an antagonist of NO produc-
tion,
6 increased CC leakage in microvessels per-
fused with GPSS at 5, 10 or 20 ml/min. At 20 ml/
min, in the presence of either a five-fold lower
(201.tM) or higher (500 l.tM) concentration of I.-
NAME, CC leakage was not significantly different
from control values (Table 3). This suggests that
20 l.tM was too low a concentration to inhibit NO
synthase. Possibly -NAME at 500 laM evoked non-
specific vascular leakage effects, in addition to
blocking NO synthesis. D-NAME (100 l.tM), which
is known to be inactive as an inhibitor of NO
synthesis,6 did not alter CC leakage (Table 2).
NO is thought to bring about vasorelaxation by
activating guanylyl cyclase. Leakage of CC was
reduced when either SNP, an activator of guanylyl
cyclase,
8 or 8BrcGMP, a membrane-permeant acti-
vator of cGMP-dependent kinase,
9 was added to
the GPSS just prior to adding L-NAME (Table 3).
These results are consistent with a significant pro-
duction of NO occurring in the absence of t-
NAME. Methylene blue, which is an NO synthase
inhibitorm as well as being an antagonist of gua-
nylyl cyclase,a also increased CC leakage (Table
2). This again is consistent with a release of NO
Table 1. Effects of changing flow rates on perfusion pressures (PP) recorded after 10 rain perfusion with GPSS or GPSS+RBC (PP 10),
and effects of adding 5HT (100 IM) or RFX (1 IM) to the perfusate for the subsequent 5 rain (PP change)
Flow rate n GPSS n GPSS + RBC n GPSS + 5HT n GPSS + RFX
ml/min PP 10 5 10.60 -t- 2.62 4 28.75 -t- 5.12
PP change 5 0.40 -t- 0.51 4 2.75 -I- 1.60
5ml/min PP 10 6 22.67 -I- 1.45 4 101.50 24.46
PP change 6 -0.33 0.21 4 5.50 __+ 2.99
lOml/min PP 10 7 37.14-i- 1.96 5 68.40___ 10.17
PP change 7 -0.71 -t- 0.64 5 2.85 1.31
20 ml/min PP 10 12 85.17 +__ 6.10 5 132.60 +__ 21.85
PP change 12 6.83 -I- 2.49 5 7.40 -t- 7.17
5 40.40 -I- 2.84 4 47.25 -I- 8.05
5 38.60 -t- 8.96
d 4 3.00 -I- 3.94
5 73.00 +__ 2.88 4 78.50 -I- 6.31
5 90.20 -t- 8.38
d 4 16.75 ___
9.51
aResults (mm Hg) are given as mean -t- S.E.M. b20% V/V RBC added at and 5 ml/min, but 10% v/v RBC at 10 and 20 ml/min. Cp < 0.05, dp < 0.005
(Bonferroni’s test) compared with PP change using GPSS alone at the same flow rate.
Table 2. Effects on CC leakage in rat small intestinal villi microvessels of adding various agents to
the GPSS perfusing the vasculature at 10 or 20 ml/min
Treatment Amount of CC leakage (as % of frame areaa)
n lOml/min n 20 ml/min
GPSS (control) 7 0.61 -t- O. 13 12 0.50 -t- 0.09
GPSS + 5HT (IO01M) 5 1.88 -I- 0.37 5 0.42 -I- 0.08
GPSS + RFX IM) 4 1.97 __. 0.44 5 0.57 O. 14
GPSS + MB (20 IM) 6 1.38 -t- 0.24
GPSS + D-NAME (100 IM) 6 0.48 ___
0.08
GPSS + CPTIO (IO01M) 6 1.58 +__ 0.26
Abbreviation not in text: MB, methylene blue. aEach frame represents one negative micrograph magnified
approximately 20 times, bValues are given as mean --t-_ S.E.M. Cp < 0.05, Bonferroni’s test compared with the
GPSS (control) value at the same flow rate.
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Table 3. Effects on CC leakage in rat small intestinal villi microvessels of adding L-NAME to the GPSS perfusing the
vasculature at perfusion rates of 10 or 20 ml/min, and their modification by various agents
Treatment L-NAME
concentration
(M) Amount of CC leakage (as % of frame areaa)
b
n 10ml/min n 20 ml/min
GPSS (Control) 7 0.61 _+ O. 13 12 0.50 ___
0.09
GPSS 20 7 0.73 -I- 0.19
GPSS 100 4 1.59 -I- 0.20 12 0.99 -t- O. 13
GPSS 500 6 O.70 ___
0.21
GPSS + SNP (1OIM) 100 6 0.58 ___
0.11
GPSS + 8BrcGMP (IO01M) 100 5 0.50 -I- O.O7
aEach frame represents one negative micrograph magnified approximately 20 times, bResults are given as mean -t- S.E.M. Cp < 0.05
(Bonferroni’s test) compared with the GPSS (control) value at the same flow rate. dp < 0.05 (Bonferroni’s test) compared with GPSS +
L-NAME (100 IM) value at the same flow rate.
occurring during perfusion in the absence of
NAME. The addition of CPTIO, an NO scaven-
ger,
2 also promoted CC leakage, thus providing
further evidence for the release .of NO (Table 2).
Possible involvement of PAF.. Addition to GPSS
perfusate of BN52021 (101.tM), an antagonist of
the effects of PAF, prior to starting exposure to
L-NAME, significantly reduced the subsequent
leakage of CC at 5, 10 and 20 ml/min. (Fig. 1). In
the absence of L-NAME, BN52021 had no effect
on CC leakage. Thus, PAF appeared not to be
involved when NO synthase was still operational,
but may have been involved in the absence of
NO.
Discussion
The reduced CC leakage found in response to
the addition of either RFX or 5HT at a perfusion
rate of 20ml/min, compared with that seen at
10ml/min, suggested that at the higher rate of
flow an endothelial cell (EC) protectant sub-
stance was being released in greater than normal
amounts, or that at the lower rate of flow a
leakage-promoting substance was being released.
Several workers have suggested that endothelium-
derived relaxant factor (EDRF), which is prob-
ably NO,
7 is released in greater than normal
amounts at high rates of vascular flow4’5 or wall
16.17 shear stress. Administration of L-NAME n our
experiments was an attempt to inhibit endogen-
ous NO production. However, the resultant
increase in CC leakage was similar at 5, 10 and
20ml/min, suggesting that even at 5 ml/min NO
secretion was occurring. Hence the difference
between responses seen in the present experi-
ments at 10 and 20ml/min more likely was due
to reduced production of a leakage-promoting
substance at the higher rate of flow than to some
variation in the rate of NO production.
Some previous workers have shown a vascular
protective role for NO,
18-21 although a pro-
inflammatory role22’23 and a dual action also have
been reported.24’25 Since these results were
obtained from different vascular beds in different
species the physiological role of NO remains
ambiguous and its likely effects are, therefore,
difficult to predict. Usually NO is considered to
relax vascular tissues by activating guanylyl
cyclase.
7 Three of our findings are relevant in
this connection. Firstly, 8BrcGMP, given prior to
L-NAME, reduced subsequent CC leakage. Sec-
ondly, treatment with methylene blue caused
additional CC leakage. Thirdly, the NO scavenger
CPTIO also increased CC leakage. Each of these
observations is consistent with NO being
involved as a normal preventer of background
leakage in this vascular bed, at least during GPSS
perfusion. However, PGI2 also is known to be
released by ECs under conditions of high shear
stress,
26-28 and ATP secretion is known to be sti-
mulated by increases in perfusion rate.29 Since
both PGI2 and ATP are vasorelaxant substances,
they also may be acting as endogenous CC
leakage inhibitors.
PAF is known to be generated by ECs in the
presence but not in the absence of L-NAME.
21 In
the present experiments pre-treatment with the
PAF inhibitor BN52021 inhibited CC leakage
induced by L-NAME, but in the absence of L-
NAME the same concentration of BN52021 failed
to reduce CC leakage (Fig. 1). Presumably the
production of PAF by vascular ECs can be sup-
pressed by the NO that is normally secreted.
Mternatively the EC-contracting effect, and hence
the leakage-promoting effect, of normal amounts
of PAF may be counterbalanced by a relaxant
effect from a concomitant secretion of NO.
At the two lower perfusion rams used here, CC
leakage in the absence of RBCs probably was
due to tissue hypoxia. Large arteries that are
exposed to hypoxia have been reported pre-
Mediators of Inflammation Vol 4 1995 347A_ M. Northover and B. J. Northover
viously to release an endothelium-dependent
vasoconstrictor substance,
3 and to develop
inherent muscular tone.3 Since the increased
permeability to CC that was seen in the present
experiments probably was brought about by
retraction of the margins of previously adjacent
microvascular ECs, resulting in the formation of
intercellular gaps,
3z the release of an EC-con-
tractile agent might explain the increase in CC
leakage during hypoxia. In the absence of L-
NAME, however, pre-treatment with BN52021 did
not reduce CC leakage, so it seems unlikely that
PAF was being formed during hypoxia as long as
NO was available. ECs are known to release
endothelins, particularly during hypoxia,33’34 and
therefore are further possible mediators of the
CC leakage seen under these circumstances.
Alternatively, hypoxia may cause EC retraction by
increasing endothelial intracellular Ca
2+ levels
directly.35 Further work will be required to sub-
stantiate or refute these suggestions.
In the presence of RBCs there was very little
CC. leakage in response to L-NAME, suggesting
that NO may be unimportant physiologically. It is
unlikely, however, that all vascular effects of NO
are precluded by normoxia since t-NAME caused
significant CC leakage with GPSS as the perfusate,
even at 20ml/min. More probably, therefore, in
the presence of RBCs, any NO is scavenged by
haemoglobin,36’37 perhaps along with other free
radicals.36 It is necessary to recognise, therefore,
that using an RBC-free perfusate may yield
experimental results that are different from those
that would be derived from a normally blood-
perfused vascular bed.
In conclusion, the present work suggests that
at both high and low rams of perfusion with
GPSS there is a release of NO, with significant
effects on the permeability of the endothelial
lining of villi microvessels. It is possible that at
low rams of perfusion with GPSS a raised intra-
cellular Ca
2 + concentration in the ECs occurs as
a result of hypoxia, and that this stimulates NO
production. At higher rates of perfusion with
GPSS, however, increased shear stresses on the
endothelium may serve the same function. Secre-
tion of PAF appears to be involved in CC leakage
only where NO production is inhibited. Micro-
vascular leakage of CC is increased under condi-
tions of limited oxygen supply, and this seems to
occur when GPSS is flowing at rates of < 10 ml/
min. Increasing the oxygen-carrying capacity of
GPSS by adding RBCs significantly decreased the
leakage of CC. At perfusion rates higher than
this, however, even in the absence of RBCs, CC
leakage was low. This suggests that an adequate
oxygen delivery with GPSS was achieved at
higher flow rams. At each perfusion rate investi-
gated a complex mixture of vasoactive agents
appears to be involved. Further investigations are
required to elucidate the nature of this mixture.
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